[1] Antinori S, Nebuloni M, Magni C, et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS:a retrospective study of 1,630 autopsies performed between 1984 and 2002[J]. Am J Clin Pathol, 2009, 132(2):221-227.
[2] Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006:overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database[J]. Clin Infect Dis, 2010, 50(8):1091-1100.
[3] Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit:results of a multicenter Italian survey (AURORA Project)[J]. Infection, 2013, 41(3):645-653.
[4] Zhang L, Xiao M, Wang H, et al. Yeast identification algorithm based on use of the Vitek MS system selectively supplemented with ribosomal DNA sequencing:proposal of a reference assay for invasive fungal surveillance programs in China[J]. J Clin Microbiol, 2014, 52(2):572-577.
[5] Guo LN, Xiao M, Cao B, et al. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China[J]. Future Microbiol, 2017, 12:1075-1086.
[6] 郭莉娜, 徐志鹏, 王瑶, 等. 微量肉汤稀释法比较分析不同培养时间念珠菌属对唑类药物的敏感性[J]. 中国真菌学杂志, 2016, 11(6):332-336.
[7] CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts[S].4th Edition. M27.
[8] Charnot-Katsikas A, Tesic V, Boonlayangoor S, et al. Prospective evaluation of the VITEK MS for the routine identification of bacteria and yeast in the clinical microbiology laboratory:assessment of accuracy of identification and turnaround time[J]. J Med Microbiol, 2014, 63(Pt 2):235-241.
[9] Turhan O, Ozhak-Baysan B, Zaragoza O, et al. Evaluation of MALDI-TOF-MS for the identification of yeast lsolates causing bloodstream infection[J]. Clin Lab, 2017, 63(4):699-703.
[10] Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive candidiasis:species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol, 2018, 56(7):e00577-18.
[11] Fan X, Xiao M, Liao K, et al. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014):molecular epidemiology and clinical azole consumption[J]. Front Microbiol, 2017, 8:464.
[12] Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty years of the SENTRY antifungal surveillance program:results for Candida species from 1997-2016[J]. Open Forum Infect Dis, 2019, 6(Suppl 1):S79-S94.
[13] Castanheira M, Messer SA, Rhomberg PR, et al. Antifungal susceptibility patterns of a global collection of fungal isolates:results of the SENTRY antifungal surveillance program (2013)[J]. Diagn Microbiol Infect Dis, 2016, 85(2):200-204.
[14] CLSI. Performance standards for antifungal susceptibility testing of yeasts[S].1st Edition. M60. |